Search Results - "Mohammed, Amrallah A"

CDK4/6 inhibitors in advanced breast cancer, what is beyond? by Mohammed, Amrallah A, Rashied, Hanaa, Elsayed, Fifi Mostafa

“…Resistant to hormonal treatment considered the main clinical challenge in the management of advanced breast cancer (ABC). The use of CDK4/6 inhibitors…”
Get full text

Response of Triple Negative Breast Cancer to Neoadjuvant Chemotherapy: Correlation between Ki-67 Expression and Pathological Response by Elnemr, Gamal M, El-Rashidy, Ahmed H, Osman, Ahmed H, Issa, Lotfi F, Abbas, Osama A, Al-Zahrani, Abdullah S, El-Seman, Sheriff M, Mohammed, Amrallah A, Hassan, Abdelghani A

Get full text

Biomarkers in prostate cancer: new era and prospective by Mohammed, Amrallah A.

“…Currently, most men are diagnosed with prostate cancer (PCa) after a prostate-specific antigen (PSA) test shows an elevated level of the PSA protein. An…”
Get full text

Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: Correlation between Androgen Receptor Expression and Pathological Response by Mohammed, Amrallah A, Elsayed, Fifi Mostafa, Algazar, Mohammed, Rashed, Hayam E, Anter, Abeer Hussien

“…There is growing evidence that the response to chemotherapy may be affected by Androgen Receptor (AR) expression suggesting that triple-negative breast cancers…”
Get full text

Urinary Bladder Cancer: Biomarkers and Target Therapy, New Era for More Attention by Mohammed, Amrallah A, El-Tanni, Hani, El-Khatib, Hani M, Mirza, Ahmad A, Mirza, Abdulrahim A, Alturaifi, Turki H

“…Currently, bladder cancer (BCa) evaluation depends mainly on traditional clinicopathological parameters encompassing tumor stage and grade, which will not…”
Get full text

End-of-life palliative chemotherapy: Where do we stand? by Mohammed, Amrallah A., Al-Zahrani, Abdullah S., Ghanem, Hafez M., Farooq, Mian U., El Saify, Amr M., EL-Khatib, Hani M.

“…This study evaluates the use of palliative chemotherapy (PCT) and possible associated factors at the end of life. The study includes all advanced non…”
Get full text

The pattern of infection and antibiotics use in terminal cancer patients by Mohammed, Amrallah A., Al-Zahrani, Abdullah S., Sherisher, Mohamed A., Alnagar, Ahmad A., EL-Shentenawy, Ayman, El-Kashif, Amr T.

“…Although cancer patients are susceptible to infection, there is no evidence-based published guideline on the appropriate use of antimicrobial treatment in this…”
Get full text

Target therapy in metastatic pheochromocytoma: current perspectives and controversies by Mohammed, Amrallah A, El-Shentenawy, Ayman M, Sherisher, Mohamed A, El-Khatib, Hani M

“…Most of the pheochromocytomas (PCCs) are benign neoplasms, but when they are malignant, they can be difficult to treat. Despite advances in diagnosis and…”
Get full text

Impact of body mass index on clinico-pathological parameters and outcome in patients with metastatic prostate cancer by Mohammed, Amrallah A., EL-Tanni, Hani, Ghanem, Hafez M., Farooq, Mian U., El Saify, Amr M., Al-Zahrani, Abdullah S., EL-Shentenawy, Ayman, EL-Khatib, Hani M.

“…This study evaluates the correlation between body mass index (BMI) and clinicopathological parameters of metastatic prostate cancer (MPC) and its impact on…”
Get full text

The application of the Glasgow prognostic score to predict the survival in patients with metastatic pancreatic carcinoma by Mohammed, Amrallah A., Al-Zahrani, Omar, Elsayed, Fifi Mostafa

“…Objectives: Thither is a more pressing effort to think about chemotherapy (CTx) in second-line and beyond in patients with metastatic pancreatic cancer (mPC)…”
Get full text

Predictive Value of IHC4 Score for Pathological Response to Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer by Elsamany, Shereef, Elmorsy, Soha, Alzahrani, Abdullah, Rasmy, Ayman, Abozeed, Waleed N, Mohammed, Amrallah A, Sherisher, Mohamed A, Abbas, Mohammed M, Mashhour, Miral

“…Purpose: This study aimed to explore the value of IHC4 in predicting pathological response after neoadjuvant chemotherapy in patients with hormonal receptor…”
Get full text

Response of Triple Negative Breast Cancer to Neoadjuvant Chemotherapy: Correlation between Ki-67 Expression and Pathological Response by Elnemr, Gamal M, El-Rashidy, Ahmed H, Osman, Ahmed H, Issa, Lotfi F, Abbas, Osama A, Al-Zahrani, Abdullah S, El-Seman, Sheriff M, Mohammed, Amrallah A, Hassan, Abdelghani A

“…Triple-negative breast cancers constitute about 15% of all cases, but despite their higher response to neoadjuvant chemotherapy, the tumors are very aggressive…”
Get full text

Predictive and Prognostic Value of Tumor- Infiltrating Lymphocytes for Pathological Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer by Mohammed, Amrallah A, Mostafa Elsayed, Fifi, Algazar, Mohammed, Rashed, Hayam E

“…Background: Tumor-infiltrating lymphocytes (TILs) reflect the antitumor response of the host. This study aimed to assess the value of TILs in predicting…”
Get more information

Impact of vitamin D serum levels on clinicopathological features and outcome in advanced pancreatic carcinoma by Mohammed, Amrallah A., Salem, Reham A.

“…Abstract Background Growing evidence encourages the preventive role of vitamin D in pancreatic carcinoma (PC). Meanwhile, the prognostic or predictive role…”
Get full text

Metastatic Triple Negative Breast Cancer: The New Era of Thinking by Mohammed, Amrallah A., Elbassuiony, Mohamed A., Rashied, Hanaa

“…The heterogeneity of triple negative breast cancer (TNBC) is reflected in a bizarre response to therapy. Although it is chemotherapy sensitive, the failure is…”
Get full text

Emergency Department Visits at the End of Life of Patients With Terminal Cancer: Pattern, Causes, and Avoidability by Alsirafy, Samy A., Raheem, Ahmad A., Al-Zahrani, Abdullah S., Mohammed, Amrallah A., Sherisher, Mohamed A., El-Kashif, Amr T., Ghanem, Hafez M.

“…Frequent emergency department visits (EDVs) by patients with terminal cancer indicates aggressive care. The pattern and causes of EDVs in 154 patients with…”
Get full text

Impact of Prognostic Nutritional Index on Terminal Cancer Patients by Mohammed, Amrallah A, Al-Zahrani, Omar, Elsayed, Fifi Mostafa

“…In terminal cancer patients (TCPs), one of the most important things is to define the survival to help the main responsible physicians, patients, and main…”
Get full text

Aggressive care at the end of life; Where are we? by Mohammed, Amrallah, Al-Zahrani, Omar, Salem, Reham, Elsayed, Fifi

“…Background: Although, efforts to encourage palliative care only for terminal patients, aggressive end-of-life care (EOL) care still common for those probably…”
Get full text

Prediction of survival outcome using Chuang's prognostic scale in metastatic breast cancer by Mohammed, Amrallah, Al-Zahrani, Omar, Elsayed, Fifi, Elshentenawy, Ayman

“…Background: For physicians and patients, survival estimation is vital for the treatment plan, especially with frequent use of new therapeutic agents in…”
Get full text

Evaluating the value of Amphiregulin, Phosphatase and Tensin Homologue (PTEN) and P21 Expression for Anti-EGFR Treatment in Metastatic Colorectal Carcinoma by Obaya, Ahmed Ali, Mohammed, Amrallah A, Rashied, Hanaa, Morsy, Adel Mahmoud, Osman, Gamal, Allam, Ahmed S, Elsayed, Ahmed M, Harb, Ola A, S H, Walid

Get full text